INSIGHTS ON DRUG DEVELOPMENT
-
Is Lipinski's Rule Of Five Still Relevant In Drug Development?
Some drugs violate multiple Ro5 elements but remain developable, while some molecules adhere strictly to the Ro5, but their properties are not conducive to development.
-
Overcoming Obstacles On The Journey To Commercialization
Explore case studies in the development and manufacturing of APIs and HPAPIs as well as innovative solutions designed to address and overcome challenges in bringing new medicines to patients.
-
A Better Immune Response To Vaccination: Using Lymphoid Follicle Organ-Chips
Discover a first-of-its-kind human LF-Chip containing B, T, plasma and antigen-presenting cells to test functional immunization responses to vaccines and adjuvants in vitro.
-
Pioneers And Visionaries Of Gene Therapy: AAV Purification
Watch as three scientists, Åsa, Anki, and Jean-Luc. share how teamwork, collaboration, and a bit of luck led them to success.
-
Cytokine-Mediated Inflammation In A Relevant Preclinical Model3/13/2024
Learn about a novel preclinical model and how it enables the study of cytokine-mediated barrier inflammation mechanisms as well as the efficacy of anti-inflammatory therapeutics.
-
Boost Drug Development Productivity With Contract Research Services2/13/2024
Find out how organ-on-a-chip contract research services are enabling the pharmaceutical industry to overcome the largest challenge in drug development—Eroom’s Law.
-
ChipChat With Emulate: Answering Your Organ-Chip Questions Live4/17/2024
Gain expert insights into fine-tuning experimental conditions, troubleshooting common challenges, and achieving reproducible and robust results with Organ-on-a-Chip technology.
-
Doubling Up For Speed In Biomanufacturing12/12/2025
Accelerate drug development and reduce risk with parallel operations. Learn how leveraging CDMO partnerships while building internal capabilities can cut costs and speed your path to market.
-
Accelerating Clinical Development: Modern Tools In Process Chemistry1/23/2025
Whether you aim to address bottlenecks or explore advanced techniques, gain a practical and forward-thinking perspective to streamline early-phase development with HTE and model-based approaches.
DRUG DEVELOPMENT SOLUTIONS
-
Enhance your research and obtain exceptional imaging and analysis with a configurable and upgradeable high-content screening system that captures high-definition images and robust data from 2D and 3D assays.
-
Over the course of 30+ years we’ve invested in and developed a broad range of expertise, a full suite of lab and analytical services, advanced technology platforms and a world-class facilities network.
-
As part of Stevanato Group’s commitment to R&D, our analytical testing facilities focus on investigating physico-chemical properties of primary packaging materials and components and studying the interactions between container closure system and drugs. Stevanato Group relies on a multi-disciplinary team of highly skilled professionals, including, scientists, engineers, pharmaceutical chemists and biotechnologists. Their knowledge and experience covers a range of specialized areas including container closure systems and drug-delivery devices.
-
Cell DIVE Multiplex Imaging Solution
What if every scientist could map normal and diseased tissue by cell type, biomarker profile, and specific features?
Cell DIVE is a precise, open multiplexing solution that lets your research dictate the level of automation required, which antibodies to use, how to build your antibody panel, and more.
-
Accelerate sterile injectable development with expert support, advanced facilities, and tailored solutions for complex APIs — from formulation through commercialization across small molecules and biologics.